7
Participants
Start Date
April 26, 2006
Primary Completion Date
May 29, 2008
Study Completion Date
May 29, 2008
PTK787/ZK 222584
Taken in tablet form daily
paclitaxel
Given as a 3-hour infusion once every 21 days
Massachusetts General Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Novartis Pharmaceuticals
INDUSTRY
Beth Israel Deaconess Medical Center
OTHER
Brigham and Women's Hospital
OTHER
Massachusetts General Hospital
OTHER
Dana-Farber Cancer Institute
OTHER